The Eisai company has got approval by the Ministry of Health of the Russian Federation on the use of antiepileptic drug Fycompa® in children
.
Saved in:
| Main Author: | article Editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2021-02-01
|
| Series: | Эпилепсия и пароксизмальные состояния |
| Online Access: | https://www.epilepsia.su/jour/article/view/627 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ministry of Public Health of the Russian Federation has Approved a Vaccine Against Herpes Zoster
by: article Editorial
Published: (2023-11-01) -
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
by: O. A. Pylaeva, et al.
Published: (2015-04-01) -
The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01) -
FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01) -
FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024-05-01)